New insights into the pharmacodynamic and pharmacokinetic properties of statins A Corsini, S Bellosta, R Baetta, R Fumagalli, R Paoletti, F Bernini Pharmacology & therapeutics 84 (3), 413-428, 1999 | 1078 | 1999 |
Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro BP Nathan, S Bellosta, DA Sanan, KH Weisgraber, RW Mahley, RE Pitas Science 264 (5160), 850-852, 1994 | 1013 | 1994 |
Safety of statins: focus on clinical pharmacokinetics and drug interactions S Bellosta, R Paoletti, A Corsini Circulation 109 (23_suppl_1), III-50-III-57, 2004 | 846 | 2004 |
HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages S Bellosta, D Via, M Canavesi, P Pfister, R Fumagalli, R Paoletti, F Bernini Arteriosclerosis, thrombosis, and vascular biology 18 (11), 1671-1678, 1998 | 756 | 1998 |
Non-lipid-related effects of statins S Bellosta, N Fed, F Bernini, R Paoletti, A Corsini Annals of medicine 32 (3), 164-176, 2000 | 500 | 2000 |
Expression of human apolipoprotein E3 or E4 in the brains ofApoE−/− mice: Isoform-specific effects on neurodegeneration M Buttini, M Orth, S Bellosta, H Akeefe, RE Pitas, T Wyss-Coray, L Mucke, ... Journal of Neuroscience 19 (12), 4867-4880, 1999 | 454 | 1999 |
Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages F Visioli, S Bellosta, C Galli Life sciences 62 (6), 541-546, 1998 | 453 | 1998 |
Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: Increased susceptibility of females J Raber, D Wong, M Buttini, M Orth, S Bellosta, RE Pitas, RW Mahley, ... Proceedings of the National Academy of Sciences 95 (18), 10914-10919, 1998 | 435 | 1998 |
Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth S Bellosta, BP Nathan, M Orth, LM Dong, RW Mahley, RE Pitas Journal of Biological Chemistry 270 (45), 27063-27071, 1995 | 376 | 1995 |
The Inhibitory Effect of Apolipoprotein E4 on Neurite Outgrowth Is Associated with Microtubule Depolymerization (∗) BP Nathan, KC Chang, S Bellosta, E Brisch, N Ge, RW Mahley, RE Pitas Journal of Biological Chemistry 270 (34), 19791-19799, 1995 | 359 | 1995 |
Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. S Bellosta, RW Mahley, DA Sanan, J Murata, DL Newland, JM Taylor, ... The Journal of clinical investigation 96 (5), 2170-2179, 1995 | 349 | 1995 |
Cholesterol: its regulation and role in central nervous system disorders M Orth, S Bellosta Cholesterol 2012 (1), 292598, 2012 | 347 | 2012 |
Disruption of the acyl-CoA: cholesterol acyltransferase gene in mice: evidence suggesting multiple cholesterol esterification enzymes in mammals VL Meiner, S Cases, HM Myers, ER Sande, S Bellosta, M Schambelan, ... Proceedings of the National Academy of Sciences 93 (24), 14041-14046, 1996 | 331 | 1996 |
Direct vascular effects of HMG-CoA reductase inhibitors S Bellosta, F Bernini, N Ferri, P Quarato, M Canavesi, L Arnaboldi, ... Atherosclerosis 137, S101-S109, 1998 | 323 | 1998 |
PPARα inhibits vascular smooth muscle cell proliferation underlying intimal hyperplasia by inducing the tumor suppressor p16INK4a F Gizard, C Amant, O Barbier, S Bellosta, R Robillard, F Percevault, ... The Journal of clinical investigation 115 (11), 3228-3238, 2005 | 223 | 2005 |
Pleiotropic effects of statins in atherosclerosis and diabetes S Bellosta, N Ferri, L Arnaboldi, F Bernini Diabetes care 23, B72, 2000 | 219 | 2000 |
Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties N Ferri, A Corsini, S Bellosta Drugs 73, 1681-1709, 2013 | 168 | 2013 |
Statin drug interactions and related adverse reactions: an update S Bellosta, A Corsini Expert opinion on drug safety 17 (1), 25-37, 2018 | 166 | 2018 |
Safety considerations for statins C Bolego, R Baetta, S Bellosta, A Corsini, R Paoletti Current opinion in lipidology 13 (6), 637-644, 2002 | 158 | 2002 |
Non-lipid-related effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors A Corsini, F Bernini, P Quarato, E Donetti, S Bellosta, R Fumagalli, ... Cardiology 87 (6), 458-468, 1996 | 151 | 1996 |